Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001640069-26-000002

Options or other derivatives

  • Director acquired 17,786 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Burstein Jennifer Director 2026-06-03 Grant or award · Director Stock Option (Right to Buy) +17,786 17,786 D
Loading xslF345X06/form4-06052026_080621.xml…